Latest Capital Markets News

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

Peel Mining has secured $21.25 million through a placement and share purchase plan, while appointing a new leadership team to drive a strategic pivot focused on unlocking value from its copper and polymetallic assets in the Cobar Basin.

NOVONIX has reached mutual agreement to draw down an additional US$40 million tranche of convertible debentures from Yorkville Advisors, advancing its funding strategy to support growth in battery technology.

Maronan Metals has released a robust Preliminary Economic Assessment for its Starter Zone, highlighting strong economics and a promising 10-year mine life, while securing $16 million in fresh capital to propel development.

Boab Metals has secured key environmental approvals and launched a $50 million capital raise to advance its Sorby Hills Lead-Silver-Zinc Project, marking a pivotal step toward production.

ikeGPS Group reports a robust first half of FY26 with a 47% increase in subscription revenue exit run rate and launches PolePilot™, an AI-driven automation tool enhancing utility network analysis.

ikeGPS has reported a robust first half of FY26 with subscription revenue soaring 47%, a successful A$24 million capital raise, and inclusion in the ASX All Ordinaries Index, underscoring its expanding footprint in the US grid modernization market.

ikeGPS Group reports a robust first half of FY26 with a 47% increase in subscription revenue exit run rate and launches AI-driven PolePilot™ to boost productivity and ARPU.

Great Northern Minerals Limited has issued a prospectus for an underwritten offer of up to 10,000 listed options at an exercise price of $0.02 each, aiming to facilitate their quotation and trading on the ASX.

Adelong Gold Limited reports significant progress in Victorian exploration with maiden drilling confirming robust gold mineralisation, while navigating a joint venture deadlock in NSW and securing a $1.25 million strategic investment.

Zelira Therapeutics has made significant progress in its HOPE 1 clinical trial program, completing a key FDA submission and securing a $650,000 non-dilutive R&D loan facility to support ongoing development and working capital needs.

Orbminco Limited has completed a promising maiden drilling program at its Majestic North Gold Project, while refreshing its board and consolidating shares to sharpen its strategic focus on Australian gold assets.